Hong Kong – 2 July 2026 – C-MER Medical Holdings Limited announced a market repurchase of 290,000 ordinary shares on 2 July 2026, according to its Next Day Disclosure Return filed with the Stock Exchange of Hong Kong.

The shares were bought back on-market at prices between HK$0.95 and HK$0.96, translating into a volume-weighted average cost of HK$0.9534 per share and an aggregate consideration of HK$0.28 million.

Following the transaction: • Issued shares (excluding treasury stock) decreased by 0.02 % to 1.21 billion. • Treasury shares increased from 20.62 million to 20.91 million. • Total issued shares remained unchanged at 1.23 billion, as the repurchased shares are being held in treasury rather than cancelled.

The buy-back was executed under the repurchase mandate approved on 20 May 2026, which authorises up to 123.23 million shares. To date, 290,000 shares—equivalent to 0.02 % of the share capital on the mandate date—have been repurchased. A moratorium on new share issues or treasury share sales is in force until 1 August 2026.